VIE Viela Bio

Viela Bio Announces Proposed Public Offering of Common Stock

Viela Bio Announces Proposed Public Offering of Common Stock

GAITHERSBURG, Md., May 26, 2020 (GLOBE NEWSWIRE) -- Viela Bio, Inc. (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced that it intends to offer and sell, subject to market and other conditions, 3,000,000 shares of its common stock in an underwritten public offering. In addition, certain selling stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock from the selling stockholders.

Morgan Stanley, Goldman Sachs & Co. LLC, Cowen and Guggenheim Securities are acting as the joint book-running managers for the offering. 

Viela Bio intends to use the net proceeds from the offering to support activities for the commercialization of inebilizumab for the treatment of NMOSD, if approved; to advance the ongoing clinical development of inebilizumab in other indications and of VIB4920, VIB7734 and other pipeline candidates; and for working capital and other general corporate purposes. Viela Bio will not receive any proceeds from any sale of shares by the selling stockholders.

The proposed offering is being made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained, when available, from:

  • Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014;
  • Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, email: , telephone: 1-866-471-2526, fax: 1-212-902-9316;
  • Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, email: , telephone: 1-833-297-2926; or
  • Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, New York, NY 10017, email: , telephone: 1-212-518-5548.

A registration statement relating to these securities was filed with the Securities and Exchange Commission on May 26, 2020 but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Viela Bio

Viela Bio, headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases.

Forward-Looking Statements



This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, contained in this press release, including statements regarding the completion, timing and size of the proposed public offering and use of proceeds therefrom, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue” or the negative of these terms or other comparable terminology, which are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various factors may cause differences between our expectations and actual results as discussed in greater detail in our filings with the Securities and Exchange Commission (SEC), including without limitation, risks and uncertainties related to global economic or market conditions, volatility in the share price of our common stock, changes in our operating plans or funding requirements and the risks and uncertainties described in the section entitled “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2019 that was filed with the SEC on March 25, 2020 and our subsequent periodic and current reports filed with the SEC. We do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Source: Viela Bio

Contacts:

Investors:
Solebury Trout
Chad Rubin
646-378-2947
 

Media:
Solebury Trout
Amy Bonanno
914-450-0349
 
EN
26/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Viela Bio

Wedbush Research
  • Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
VIRC VIRCO MANUFACTURING CORP.
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MYOK MYOKARDIA INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
ICPT INTERCEPT PHARMACEUTICALS INC.
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
FRX_CN FENNEC PHARMACEUTICALS
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
VRNA VERONA PHARMA ADS
AMD ADVANCED MICRO DEVICES INC.
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
UBX UNITY BIOTECHNOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
PRVL PREVAIL THERAPEUTICS
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
IDYA IDEAYA BIOSCIENCES
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
BDTX INC.
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
INZY ITEOS THERAPEUTICS
GBIO INOZYME PHARMA
GRAY GENERATION BIO
CYT GRAYBUG VISION
AVTE CYTEIR THERAPEUTICS
TCRR INC
CMPX AEROVATE THERAPEUTICS
INC.
TCR2 THERAPEUTICS INC
COMPASS THERAPEUTICS
Andreas Argyrides ... (+6)
  • Andreas Argyrides
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MYOK MYOKARDIA INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
ICPT INTERCEPT PHARMACEUTICALS INC.
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
FRX_CN FENNEC PHARMACEUTICALS
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
VRNA VERONA PHARMA ADS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
PRVL PREVAIL THERAPEUTICS
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
IDYA IDEAYA BIOSCIENCES
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
BDTX INC.
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
INZY ITEOS THERAPEUTICS
CYT INOZYME PHARMA
AVTE CYTEIR THERAPEUTICS
TCRR INC
AEROVATE THERAPEUTICS
INC.
TCR2 THERAPEUTICS INC
Andreas Argyrides ... (+5)
  • Andreas Argyrides
  • David Nierengarten
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
ICPT INTERCEPT PHARMACEUTICALS INC.
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ALXN ALEXION PHARMACEUTICALS INC.
ACOR ACORDA THERAPEUTICS INC.
ABUS ARBUTUS BIOPHARMA CORP.
FRX_CN FENNEC PHARMACEUTICALS
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ALNA ALLENA PHARMACEUTICALS
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
APTX APTINYX
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
TCRR TCR2 THERAPEUTICS
HARP HARPOON THERAPEUTICS
BCEL ATRECA
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
AQST AQUESTIVE THERAPEUTICS
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
PRAX INC.
PRAXIS PRECISION MEDICINES
Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
ICPT INTERCEPT PHARMACEUTICALS INC.
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
DBD DIEBOLD NIXDORF INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ALXN ALEXION PHARMACEUTICALS INC.
ACOR ACORDA THERAPEUTICS INC.
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
BBBY BED BATH & BEYOND INC.
EA ELECTRONIC ARTS INC.
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ALNA ALLENA PHARMACEUTICALS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
APTX APTINYX
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
TCRR TCR2 THERAPEUTICS
HARP HARPOON THERAPEUTICS
SCPL SCIPLAY
BCEL ATRECA
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
AQST AQUESTIVE THERAPEUTICS
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
U INC.
BEAM UNITY SOFTWARE INC.
PRAX BEAM THERAPEUTICS
SKLZ PRAXIS PRECISION MEDICINES
PLTK SKILLZ INC (A)
PLAYTIKA HOLDING
Andreas Argyrides ... (+6)
  • Andreas Argyrides
  • David Nierengarten
  • Kenneth Shields
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
ICPT INTERCEPT PHARMACEUTICALS INC.
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ALXN ALEXION PHARMACEUTICALS INC.
ACOR ACORDA THERAPEUTICS INC.
ABUS ARBUTUS BIOPHARMA CORP.
FRX_CN FENNEC PHARMACEUTICALS
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ALNA ALLENA PHARMACEUTICALS
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
APTX APTINYX
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
TCRR TCR2 THERAPEUTICS
HARP HARPOON THERAPEUTICS
BCEL ATRECA
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
AQST AQUESTIVE THERAPEUTICS
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
PRAX INC.
PRAXIS PRECISION MEDICINES

ResearchPool Subscriptions

Get the most out of your insights

Get in touch